Skip to main content
. 2019 Oct 22;34(2):e23045. doi: 10.1002/jcla.23045

Table 2.

Correlation of tumor circ‐LARP4 expression with clinical features

Clinical features Circ‐LARP4 low expression (n = 36)* Circ‐LARP4 high expression (n = 36)* P value
Age, No. (%)
<18 y 19 (52.8) 19 (52.8) 1.000
≥18 y 17 (47.2) 17 (47.2)  
Gender, No. (%)
Female 16 (44.4) 14 (38.9) .633
Male 20 (55.6) 22 (61.1)  
Tumor location, No. (%)
Femur 18 (50.0) 20 (55.5) .750
Tibia 14 (38.9) 11 (30.6)  
Others 4 (11.1) 5 (13.9)  
WHO classification of sarcoma, No. (%)
Conventional: chondroblastic 5 (13.9) 5 (13.9) .755
Conventional: osteoblastic 25 (69.5) 22 (61.1)  
Conventional: other 3 (8.3) 6 (16.7)  
Telangiectatic 3 (8.3) 3 (8.3)  
Pathological fracture, No. (%)
No 27 (75.0) 31 (86.1) .234
Yes 9 (25.0) 5 (13.9)  
Enneking stage, No. (%)
IIA 2 (5.6) 9 (25.0) .022
IIB 34 (94.4) 27 (75.0)  
Surgery type, No. (%)
Amputation 11 (30.6) 10 (27.8) .759
Limb salvage 25 (69.4) 26 (72.2)  
*

Low expression and high expression were categorized by the median value of circ‐LARP4 relative expression in tumor. Comparison was determined by the chi‐square test. WHO: World Health Organization.